SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 8, 2026

MIRM

Mirum Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 2 insiders, $707K total
Actionable Insight • Neutral

Insider selling is immaterial relative to market cap and likely reflects routine personal liquidity or tax planning. No directional signal for MIRM shares. Monitor for larger insider transactions or accompanying corporate events (e.g., earnings, M&A) that could change the context.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$127.70
T+0 close · Jul 8, 2026 · via day close
Latest settled
−35.06%
T+60 · $82.93
Vs SPY
−37.44%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 9 $127.70entry
  2. T+1 · 4mo ago −4.36%α −4.79% · $122.13
  3. T+5 · 4mo ago −8.10%α −7.97% · $117.36
  4. T+20 · 3mo ago −26.30%α −28.54% · $94.12
  5. T+60 · 7w ago −35.06%α −37.44% · $82.93
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Mirum Pharmaceuticals insiders (CFO Eric Bjerklholt and SVP/Global Controller Jolanda Howe) sold a combined $707K in open-market shares over a one-week window. The total sales represent less than 0.01% of the $7.8B market cap, making the cluster economically trivial and uninformative for stock direction.

Key Financial Metrics

Direction
selling
Total Value
$707.0K
Insiders
2

Key Facts

  • CFO Eric Bjerklholt sold 3,100 shares at $121.67 on July 6, 2026, worth ~$380K
  • SVP/Global Controller Jolanda Howe sold 2,718 shares at $120.00 on July 1, 2026, worth ~$327K
  • Total insider sales of $707K represent less than 0.01% of MIRM's $7.8B market cap
  • No other insiders traded; cluster is small and isolated

Financial Impact

Negligible, $707K in insider sales, <0.01% of market cap

dilutioninsider ownership

Risk Factors

  • Minimal from this filing; no material risk indicated

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MIRM-1783576941195

US Market Status

Market Closed · Opens in 8h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 9, 2026